Primary Site >> Colorectal Cancer
Gene >> CCL3
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Macrophage inflammatory protein (mip)-1-alpha stem-cell inhibitor (sci) does not affect clonal growth of human solid tumor-cell lines in-vitro. PMID: 21566931 |
Ref: Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity. PMID: 14500387 |
Ref: Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN. PMID: 15548360 |
Ref: Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes. PMID: 17667525 |
Ref: Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1alpha and VEGF. PMID: 21268133 |
Ref: Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. PMID: 22469976 |
Ref: Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice. PMID: 24510316 |
Ref: Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation. PMID: 27340784 |
Ref: CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNgamma with Dependency on Natural Killer Cells. PMID: 29109732 |
Ref: Circulating Inflammatory Markers and Colorectal Cancer Risk: A Prospective Case-cohort Study in Japan. PMID: 30132835 Ref: Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis. PMID: 30202097 |